Back to mobile site

Citi Reiterates Buy Rating on 10X Genomics (TXG)

October 10, 2024 5:51 AM EDT Send to a Friend
Citi analyst Patrick Donnelly reiterated a Buy rating and $35.00 price target on 10X Genomics (NASDAQ: TXG).The analyst comments "TXG ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login